Abstract
I. Introduction
Percutaneous biopsy yields tissue samples for diagnosis and staging and facilitates differentiation of primary cancer from distant metastasis or infective and inflammatory lesions, which is crucial for correct management of lung lesions (1) . Percutaneous biopsy has also been used to obtain tissue for genetic and immunologic testing of cancer mutations, thus improving the care of patients undergoing targeted chemotherapy (2, 3) . Imaging -guided percutaneous trans-thoracic biopsy has become a widely accepted , effective, and safe minimally invasive technique with which to obtain tissue specimens from a number of different intra-thoracic lesions (4) (5) (6) .
Computed tomography (CT) is the most common guidance technique for percutaneous trans-thoracic interventional procedures, as it provides relevant information about needle trajectory within the lung (4, 7, 8) . However, conventional CT guidance does not allow for real-time monitoring of both needle movement and lesion displacement with respiration. To overcome these limits, CT fluoroscopy has been introduced recently. This tool allows for continuous monitoring of both lung movements and needle course as it progresses toward the lesion (9-11) however , both of these imaging modalities use a large amount of ionizing radiation and are capable of providing only axial sections of the lung in real time (6, 12) . In the chest, the role of ultrasonography (US) has traditionally been limited when compared with CT, since US waves are not able to penetrate aerated tissue (13) . As a consequence, US has mainly been used to evaluate pleural effusion , pneumothorax, and pulmonary fibrosis and to serve as guidance for thoracentesis and chest tube placement (13) (14) (15) . However, US has been described as a useful tool in the characterization of undetermined pleural or sub-pleural pulmonary nodules (13, 16) when no aerated lung is interposed in between . Also, US can be used as a safe and effective method with which to guide biopsies of masses abutting the chest wall (5, (17) (18) (19) (20) . Major advantages of this imaging modality are that US enables real time multiplanar monitoring of the procedure and can be performed at the patient bedside, without the use of ionizing radiation . This study was conducted to compare the outcome of CT and US guidance when sampling peripheral pleuropulmonary lesions . PATIENTS AND METHODS Patients:. Institutional review board approval was obtained, and the need for patient informed consent was waived. We retrospectively reviewed our case series of patients who underwent pulmonary biopsy with imaging guidance at Damanhour oncology center from January 2009 to March 2012. In this period 260 patients who had pleural or peripherally located lung lesions with at least a small amount of contact with the pleura entered our analysis .Demographics and data regarding anatomic position of nodules are reported in table 1.
CT and US Guidance Technique
All procedures were performed of without the use of a specific protocol. However patient group was homogenous for anatomic location of the lesion, which included both peripheral pulmonary and pleural lesions (Table 1) CT guidance was performed by using 4-section multi-detector CT system (Toshiba Asteion 4 slice) . Patients were positioned on CT table in prone, supine, or lateral decubitus position depending on the location of the lesion, to obtain the most direct route for biopsy. The skin entry site was marked by using the laser light from the CT gantry. The skin was cleaned with 10% iodopovidine (or a mixture of 2% chlorexidine gluconate and 70 % ethyl alcohol if the patient had an allergy to iodine). Local anesthetic (up to 10 mL of 2% mepivacaine hydrochloride without adrenaline) was injected up to the pleural surface . At this moment, needle position was checked By performing a CT scan. Thereafter, the anesthesia needle was removed and the biopsy needle was advanced through the thoracic wall and the pleura . CT images were used to confirm the correct placement of the biopsy needle within the lesion (fig1).
US guidance was performed by using a US system (Toshiba, Xario 200 ) equipped with a 3.5-5.0 MHz convex probe. Patient position was decided according to the best way to reach the lesion. The US probe was covered by a sterile condom to ensure complete sterilization after administration of local antiseptic and anesthetic, the biopsy needle was inserted by using a sterile puncture transducer with a needle -guide attachment with different angle selection or a freehand out-of-plane approach (fig2a&b). the biopsy needle was then advanced into the lesion with real time visualization . All sample were acquired by using an 18 -gauge modified Menghini needle ( Length range 10-15 cm) and all specimens were placed in formaldehyde-filled sterile container . 
Figure 2b US guided biopsy of peripheral lung lesion (the needle is clearly seen (black arrow).

Post-procedure Care
After US-and CT-guided biopsy, patient were monitored for about 30 minutes after that a low -dose CT scan was performed through the whole chest to demonstrate the presence of post-procedural pneumothorax or intraparenchymal hemorrhage . Data Analysis Maximum diameter of lesions was recorded. Duration of both CT-and US-guided procedures was evaluated on the basis of picture archiving and communication system (PACS) storage time starting with the first image used to localize the lesion and ending with last image used as post-procedural control. Technical success evaluation and biopsy results were based on a review of histopathology records.
Cost
The cost of the procedure was calculated on the basis of global operational expenditures incurred by hospital for operators, use of the room, syringes, needles, and drugs. All these data were provided by the regional health administration.
Statistical Analysis
Age and maximum lesion diameter in patient who underwent CT-guided biopsy were compared with those of patient who underwent US-guided biopsy by using Mann -Whitney U test. Procedure duration for patient who underwent CT-guided biopsy was compared with that for patient who underwent US-guided biopsy by using the log-rank test, sex, lesion location (pleural or peripheral pulmonary) , technical success (sample adequacy for pathological diagnosis), and post-procedural pneumothorax rate for patient who underwent CT-guided biopsy were compared with those who underwent US-guided biopsy by using the Fisher exact test. A P value less than .05 was considered indicative of a significant difference. SPSS software (version 17.0:IBM.
Armonk, NY) was used.
Results
The target was reached successfully in all cases with both guidance techniques. No significant difference was found between patient who underwent US-guided biopsy and patients who underwent CT-guided biopsy with regards to patient,s age, sex , lesion size, and lesion origin (P> .206). Detailed data are reported in Table 1 . CT guided procedures had a comprehensive cost of about 430 LE for pleural or peripheral lung lesion , while US-guided procedures had a comprehensive cost of about 320 LE for both pleural and peripheral lung lesions. Disccusion Our experience demonstrated that US guidance is as accurate as CT guidance in obtaining adequate samples from pleural and peripheral lung lesions. Also, in our series, the use of US guidance led to a significant reduction in mean procedural time and post procedural pneumothorax incidence when compared with CT guidance . CT provides excellent contrast and spatial resolution and enables accurate needle placement, making it the most widely used guidance technique for percutaneous trans-thoracic interventional procedures (4, 7, 8) . However, the use of ionizing radiation , the lack of real time capability, and the visualization of only transverse sections are the major limitations of CT guidance. This specially true with small lesions or those that are difficult to sample, where multiple sections acquisitions and needle re-positioning may be necessary. These complications can increase patient discomfort , as well as the length of time during which the needle is positioned across the pleura . The introduction of CT fluoroscopy has overcome the limitation of real-time needle visualization during CT-guided procedures, but it still provides only transverse sections and introduces a substantial amount of radiation exposure to both patient and operator (6) .
On the other hand, real time guidance can be performed by using US, making the procedure faster and free of ionizing radiation. In addition, US equipment is less expensive than CT systems and is generally more widely available. Portable US machines can also be moved to the patient,s bedside, so the procedure can be performed at the bedside of critically ill patients and those situated in different positions, such as semi-sitting decubitus position in patients with dyspnea who cannot tolerate prone or supine positioning .
In 84 consecutive patients who underwent percutaneous trans-thoracic biopsies, Sheth et al (20) were able to perform US guided biopsy in 40% of their patient , with a correct diagnosis in 91% of them. Moreover transthoracic US was demonstrated to be as effective as chest radiography in the detection of pneumothorax after trans-thoracic US-guided lung biopsy , thus allowing monitoring of post-procedural complication , as well (21) . This last option we was not used in our series , as we always used a CT scan to demonstrate the presence of post-procedural pneumothorax or hemorrhage . Our results demonstrated that US-guided biopsy is as accurate as CT-guided biopsy in the diagnosis of peripheral pulmonary or pleural lesions. This is somewhat intuitive, as once the needle is placed correctly, ,sampling is performed with the same needle in the same way . In our study , we found two main benefits of US guidance when performing lung biopsies, First ,US guidance allowed for a significantly (46%) shorter procedure time , as needle placement and biopsy can be performed during one breath hold , this is particularly useful in small mobile basilar lesion , when even a slight variation in respiratory excursion can affect the position of the lesion, and in non-collaborative patients with dyspnea, in whom it is particularly difficult to obtain a prolonged and stable breath hold , together with reducing patient discomfort , this decreases the time the needle is placed across the pleura . Second we found a significantly lower incidence of post-procedural pneumothoraxes in patients who underwent US-guided procedures compared with those who underwent CT-guided biopsy. These data can be explained by the fact that real-time monitoring with US guidance enables a more straightforward puncture of the lesion, thus preventing the possible multiple punctures that are sometimes needed when sampling is performed with CT guidance. Also, a reduction of procedural time could be have positively conditioned the lower incidence of post-procedural pneumothoraxes in patients who underwent US-guided sampling. Sheth et al (20) needed 1884 seconds to perform US-guided thoracic biopsy. The value in our study are far lower than the values in their study. This can be explained by the fact that they considered the whole duration of the procedure , while our data merely are based on PACS storage timing , thus, our values represent an underestimation of the time needed to perform CT-or US-guided thoracic biopsy overall, but they can still be used for a reliable comparison between patients included in our series . Pneumothorax is the most common complication of CT-guided trans-thoracic pulmonary biopsy with a reported frequency between 2.8%and 46%(6.13.21.22). Our overall value of 11.2% sits within the range . Similarly, intra-parenchymal hemorrhage is an uncommon event when dealing with pleural or peripheral lung lesions (20) . In our series, we found three cases in which post-procedual CT showed a thin blood layer around the lesion. Adequacy rate of peripheral pulmonary or pleural lesion biopsy performed with a non fine needle is reported to be between 89.5% and 97% with CT guidance (6, 9, 10, 23) and between 76%and 96 % with US guidance (17, 19, 20) . Our values are comparable with those reported in the literature.
Cost is another important factor to consider, if one assumes that no difference exist between CT and US guidance in the terms of safety and diagnostic accuracy, US-guided procedures less expensive than CT-guided procedures. We should highlight that the amount ionizing radiation administrated with a CT guided procedure can not be considered negligible.
In summary, when dealing with pleural or peripheral lung lesions, US guidance is comparable to CT in terms of sample accuracy, while allowing for a significant reduction in procedure time and post-procedural pneumothrax, without the use of ionizing radiation.
